[PDF][PDF] Peginterferon alpha2a is associated with higher sustained virological response than peginterferon alfa2b in chronic hepatitis C: systematic review of …

T Awad, K Thorlund, G Hauser, D Stimac… - …, 2010 - Wiley Online Library
A combination of weekly pegylated interferon (peginterferon) alpha and daily ribavirin
represents the standard of care for the treatment of chronic hepatitis C according to current …

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized …

T Awad, K Thorlund, G Hauser, D Stimac… - …, 2010 - portal.findresearcher.sdu.dk
A combination of weekly pegylated interferon (peginterferon) alpha and daily ribavirin
represents the standard of care for the treatment of chronic hepatitis C according to current …

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized …

T Awad, K Thorlund, G Hauser, D Stimac… - …, 2010 - turing.iimas.unam.mx
A combination of weekly pegylated interferon (peginterferon) alpha and daily ribavirin
represents the standard of care for the treatment of chronic hepatitis C according to current …

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized …

T Awad, K Thorlund, G Hauser, D Štimac… - Hepatology (Baltimore …, 2010 - croris.hr
Sažetak A combination of weekly pegylated interferon (peginterferon) alpha and daily
ribavirin represents the standard of care for the treatment of chronic hepatitis C according to …

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized …

T Awad, K Thorlund, G Hauser, D Stimac… - Hepatology …, 2010 - europepmc.org
Conclusion Current evidence suggests that peginterferon alpha-2a is associated with higher
SVR than peginterferon alfa-2b. However, the paucity of evidence on adverse events curbs …

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized …

T Awad, K Thorlund, G Hauser, D Stimac… - …, 2010 - research.regionh.dk
A combination of weekly pegylated interferon (peginterferon) alpha and daily ribavirin
represents the standard of care for the treatment of chronic hepatitis C according to current …

[引用][C] Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of …

T AWAD - Hepatology, 2010 - cir.nii.ac.jp
Peginterferon alpha-2a is associated with higher sustained virological response than
peginterferon alfa-2b in chronic hepatitis C : systematic review of randomized trials | CiNii …

[引用][C] Peginterferon alpha-2a Is Associated with Higher Sustained Virological Response than Peginterferon alfa-2b in Chronic Hepatitis C: Systematic Review of …

T AWAD, K THORLUND, G HAUSER… - Hepatology …, 2010 - pascal-francis.inist.fr
Peginterferon alpha-2a Is Associated with Higher Sustained Virological Response than
Peginterferon alfa-2b in Chronic Hepatitis C: Systematic Review of Randomized Trials CNRS …

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized …

T Awad, K Thorlund, G Hauser… - Hepatology …, 2010 - pubmed.ncbi.nlm.nih.gov
A combination of weekly pegylated interferon (peginterferon) alpha and daily ribavirin
represents the standard of care for the treatment of chronic hepatitis C according to current …

Peginterferon alpha2a is associated with higher sustained virological response than peginterferon alfa2b in chronic hepatitis C: Systematic review of randomized …

T Awad, K Thorlund, G Hauser, D Stimac, M Mabrouk… - Hepatology, 2010 - infona.pl
A combination of weekly pegylated interferon (peginterferon) alpha and daily ribavirin
represents the standard of care for the treatment of chronic hepatitis C according to current …